Ata­lan­ta gets $97M boost to take two siR­NAs in­to clin­ic for rare neu­ro dis­or­ders

For five years, Ata­lan­ta Ther­a­peu­tics op­er­at­ed with one in­vestor.

Now, F-Prime Cap­i­tal is get­ting a bevy of fi­nan­cial sup­port to pro­pel two of the Boston …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER